Interlace Scores Series B

Interlace Medical Inc., a Newton, Mass.-based developer of medical devices for the in-office polypectomy/myomectomy market, has secured $3 million of a $5 million Series B round, according to a regulatory filing. Backers include Spray Venture Partners and New Leaf Ventures.